Plus Therapeutics, Inc. | CYTX - Assets


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Plus Therapeutics, Inc.

Plus Therapeutics, Inc. reported $15.64M in Assets for its fiscal quarter ending in March of 2023.


Assets Change
Baxter International BAX:US USD 28.29B 4M
Cerus CERS:US USD 209.34M 8.76M
Haemonetics HAE:US USD 1.93B 56.76M
Infinity Pharmaceuticals INFI:US USD 29.95M 12.2M
Merrimack Pharmaceuticals MACK:US USD 19.63M 201K
Mirati Therapeutics MRTX:US USD 1.03B 168.89M
Northwest Biotherapeutics NWBO:US USD 32.87M 1.55M
Plus Therapeutics, Inc. CYTX:US USD 15.64M 8.23M
Starpharma Holdings Ltd SPL:AU AUD 57.65M 8.53M
Teva Pharmaceutical Industries Ltd TEVA:IT USD 43.46B 550M